This device is used for temporary endoscopic drainage of the biliary duct through the nasal passage by use of an indwelling catheter.
Device Story
The Nasal Biliary Drainage Set is an endoscopic device used for temporary biliary duct drainage. It consists of a drainage catheter, nasal transfer tube, drainage connecting tube, and pigtail straightener. The catheter, featuring anti-migration elements (pigtails, duodenal loops, or curved tips) and side ports, is placed endoscopically over a wire guide. A nasal transfer tube facilitates routing the catheter from the oral cavity out through the nostril. A touhy-borst connector allows for flushing and connection to a drainage tube, which includes a three-way stopcock for flow control and connects to a collection bag. The device is radiopaque for fluoroscopic positioning. Used by clinicians in a clinical setting, the device provides external biliary drainage, aiding in decompression and patient management.
Clinical Evidence
Bench testing only. No clinical data provided. Testing included biocompatibility (ISO 10993-1), simulated use, dimensional verification, resistance to collapse, flow rate, tensile strength, leakage, radiopacity, marker band attachment/corrosion post-exposure to simulated gastric/bile environments, MRI compatibility, and shelf-life testing.
Technological Characteristics
Materials include radiopaque polyethylene and polyvinylchloride. Features include anti-migration tips (pigtail, loop, curved), side ports, and touhy-borst connectors. Compatible with 0.035" wire guides. Radiopaque for fluoroscopic visualization. Sterilized via ethylene oxide. Single-use only.
Indications for Use
Indicated for temporary endoscopic drainage of the biliary duct via an indwelling catheter routed through the nasal passage in patients requiring biliary decompression.
Regulatory Classification
Identification
A biliary catheter and accessories is a tubular flexible device used for temporary or prolonged drainage of the biliary tract, for splinting of the bile duct during healing, or for preventing stricture of the bile duct. This generic type of device may include a bile collecting bag that is attached to the biliary catheter by a connector and fastened to the patient with a strap.
Special Controls
*Classification.* Class II (special controls). The device, when it is a bile collecting bag or a surgical biliary catheter that does not include a balloon component, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.
Predicate Devices
Cook Endoscopic Nasal Biliary Drainage Set (K896323)
K023870 — FLEXIMA BILIARY CATHETER · Boston Scientific/Medi-Tech · Dec 20, 2002
K121832 — RESOLVE BILIARY LOCKING DRAINAGE CATHETER · Merit Medical Systems, Inc. · Jul 17, 2012
K031360 — GI SUPPLY BILIARY STENT · Gi Supply · Sep 24, 2003
K982508 — FLEXIMA · Boston Scientific Corp · Oct 16, 1998
Submission Summary (Full Text)
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). The FDA logo is composed of two parts: the Department of Health & Human Services logo on the left and the FDA acronym along with the full name of the agency on the right. The FDA acronym is in a blue box, and the full name of the agency, "U.S. Food & Drug Administration," is in blue text.
July 6, 2018
Cook Ireland Ltd. Jacinta Kilmartin Regulatory Affairs Manager O'Halloran Road, National Technology Park Limerick Ireland
Re: K180868
> Trade/Device Name: Nasal Biliary Drainage Set, Liguory Nasal Biliary Drainage Set, Nagaraja Nasal Biliary Drainage Set, Leung Nasal Biliary Drainage Set Regulation Number: 21 CFR& 876.5010 Regulation Name: Biliary Catheter and Accessories Regulatory Class: II Product Code: FGE Dated: June 21, 2018 Received: June 25, 2018
Dear Jacinta Kilmartin:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies.
{1}------------------------------------------------
You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Image /page/1/Picture/6 description: The image shows the FDA logo on the left. To the right of the logo is the text "Jeffrey W. C" followed by the date "2018.07.06" and the time "-04'00'". The text is black and the background is white.
Jeffrey W. Cooper -S 2018.07.06 17:28:21
for Benjamin R. Fisher, Ph.D. Director Division of Reproductive, Gastro-Renal, and Urological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
# Indications for Use
### 510(k) Number (if known) K180868
### Device Name
Nasal Biliary Drainage Set, Liguory Nasal Biliary Drainage Set, Nagaraja Nasal Biliary Drainage Set, Leung Nasal Biliary Drainage Set
### Indications for Use (Describe)
This device is used for temporary endoscopic drainage of the biliary duct through the nasal passage by use of an indwelling catheter.
| Type of Use (Select one or both, as applicable) |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| <div style="display:flex; align-items:center;"> <input checked="true" type="checkbox"/> <span>For activities identified in 33 CFR 160.3, Subpart C</span> </div> |
| <div style="display:flex; align-items:center;"> <input type="checkbox"/> <span>Other - For activities not identified in 33 CFR 160.3, Subpart C</span> </div> |
X | Prescription Use (Part 21 CFR 801 Subpart D)
| | Over-The-Counter Use (21 CFR 801 Subpart C)
## CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
## *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
{3}------------------------------------------------
K180868: Nasal Biliary Drainage Set, Liguory Nasal Biliary Drainage Set, Nagaraja Nasal Biliary Drainage Set, Leung Nasal Biliary Drainage Set
# Section 5: 510(k) Summary
#### I. SUBMITTER
Cook Ireland Ltd. O' Halloran Road National Technology Park Limerick Ireland
Phone: +353 61 334440 Fax: +353 61 239293
Contact Person: Jacinta Kilmartin, Regulatory Affairs Manager
Phone: +353 61 334440 Fax: +353 61 239293
Date Prepared: Jul 06, 2018
#### II. DEVICE
- Trade Name of Device: Nasal Biliary Drainage Set, Liguory Nasal Biliary Drainage Set, Nagaraja Nasal Biliary Drainage Set, Leung Nasal Biliary Drainage Set
The model numbers are
ENBD-X, ENBD-X-LIGUORY, ENBD-X-LIGUORY-RT, ENBD-X-NAG, ENBD-X-LEUNG-Y.
The X in the model number denotes the catheter Fr size and the Y denotes the number of drainage ports on the catheter.
Common or Usual Name: Drainage Catheter
{4}------------------------------------------------
Classification Name: Biliary Catheter and Accessories (21 CFR 876.5010) Regulatory Class: II Product Code: FGE
#### III. PREDICATE DEVICE
Predicate: Cook Endoscopic Nasal Biliary Drainage Set cleared under 510(k) K896323 cleared on April 09, 1990
#### DEVICE DESCRIPTION IV.
The subject device consists of a drainage catheter, nasal transfer tube, drainage connecting tube and pigtail straightener (provided with drainage catheters which have a pigtail configuration at the distal end). The drainage catheter has anti-migration features, side ports and a touhy-borst connector. The anti-migration features (which include pigtails, duodenal loops and a curved tip) help prevent migration enabling the drainage catheter to remain in the desired position. The side ports, also located at the distal end of the drainage catheter assist in the drainage of bile. The touhy-borst connector allows connection of the drainage catheter to the drainage connection tube; it also allows the drainage catheter to be flushed. The drainage connection tube allows the drainage catheter to be connected to a drainage collection bag. In the middle of the drainage connecting tube is a three way stopcock; this allows a flow through the drainage connecting tube during the procedure. The nasal transfer tube enables the drainage catheter to be threaded through the oral cavity and out through the nostril. The drainage catheter contains radiopaque material which allows the user to ensure the drainage catheter is accurately positioned using fluoroscopically.
#### V. INDICATIONS FOR USE
This device is used for temporary endoscopic drainage of the biliary duct through the nasal passage by use of an indwelling catheter.
The indications for use statement for the subject device is not identical to the predicate device; however, the differences do not alter the intended therapeutic use of the device nor do they affect the safety and effectiveness of the device relative to the predicate. The subject and predicate device have the same intended use, drainage of the biliary duct through the nasal passage.
{5}------------------------------------------------
K180868: Nasal Biliary Drainage Set, Liguory Nasal Biliary Drainage Set, Nagaraja Nasal Biliary Drainage Set, Leung Nasal Biliary Drainage Set
### VI. COMPARISON OF TECHNOLOGICAL CHARACTERISTICS WITH A PREDICATE DEVICE
The subject device is substantially equivalent to the currently marketed predicate, the Cook Endoscopic Nasal Biliary Drainage Set cleared under the following 510(k): K896323 cleared on April 09, 1990
In brief, the subject device has the same intended use and technological characteristics as the predicate Cook Endoscopic Nasal Biliary Drainage Set with respect to the following:
- Both devices have the same intended use for duct drainage. .
- . Both devices are used in the biliary duct.
- . Both devices are used for external drainage via the nasal cavity.
- . Both devices contain the following components; Drainage Catheter (with touhy-borst connector), Nasal Transfer Tube and Drainage Connecting Tube.
- . The subject device is offered in a number of lengths; one length (250cm) matches that of the predicate.
- The following drainage catheter diameters are in common between the subject and ● predicate devices: 5, 6, 7, and 10 Fr.
- . Certain models of the subject device share a common drainage catheter material with the predicate device. Radiopaque Polyethylene.
- . Both drainage catheters have side ports to assist drainage.
- Both drainage catheters share types of anti- migration features.
- Both Nasal Transfer Tubes are composed of Polyvinylchloride and are 50cms in length.
- Both Drainage Connecting Tubes are composed of Polyvinyl chloride
- Both devices are visible under fluoroscopy (radiopaque). ●
- Both devices are placed endoscopically over a wire guide.
- Both sets are compatible with 0.035'' wire guides. ●
- Both devices are for professional use.
- . Both devices are intended for single use only.
- Both devices are supplied sterile and are sterilised using ethylene oxide. .
{6}------------------------------------------------
The following technological differences exist between the subject device and the Cook Endoscopic Nasal Biliary Drainage Set, predicate device:
- i) Components supplied
- ii) Dimensions
- iii) Features-Marker Bands, Number of Side Ports and Curved Tip Feature
- iv) Drainage Catheter Materials
#### VII. PERFORMANCE DATA
The biocompatibility evaluation for the subject device was conducted in accordance with the FDA's Use of International Standard ISO 10993-1,"Biological evaluation of medical devices -Part 1: Evaluation and testing within a risk management process" June 16, 2016 and International Standard ISO 10993-1 "Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process" (ISO10993-1:2009).
Testing performed included simulated use, dimensional verification. resistance to collapse, flow rate, tensile, leakage, radiopacity, testing (tensile and marker band attachment/ corrosion) post exposure to simulated gastric environment (in simulated bile), MRI and shelf life testing.
Testing was performed as per Cook Ireland's design control system.
#### VIII. CONCLUSIONS
The non-clinical data supports the safety of the subject device and demonstrates that the subject device is safe and effective and should perform as intended in the specified use conditions. This non-clinical data supports the substantial equivalence of the subject device to the predicate device.
Panel 1
/
Sort by
Ready
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.